Clarius Group, LLC
- SEC CIK
- 0001664214
- Latest filing
- Jan 14, 2026
SAGE holding history
Sage Therapeutics, Inc. in every 13F filed by Clarius Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SAGE overviewAll 13F holders of SAGEFull Q4 2025 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −10,000−100.0% | Sold out | Holders |
| Q2 2025 | 10,000 | $91.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 10,000 | $79.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 10,000 | $54.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 10,000 | $72.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 10,000 | $108.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 10,000 | $187.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 10,000 | $216.7K | <0.1% | −994−9.0% | Reduced | Holders |
| Q3 2023 | 10,994 | $226.3K | <0.1% | +240+2.2% | Added | Holders |
| Q2 2023 | 10,754 | $505.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 10,754 | $451.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 10,754 | $410.0K | <0.1% | +28+0.3% | Added | Holders |
| Q3 2022 | 10,726 | $420.0K | <0.1% | +549+5.4% | Added | Holders |
| Q2 2022 | 10,177 | $329.0K | <0.1% | +10,177 | New | Holders |